Education
About Us
Working with TipRanks
Follow Us
Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 675.04M | $ 482.38M | $ 401.86M | $ 365.98M | $ 353.87M |
| Gross Profit | $ 664.16M | $ 475.89M | $ 396.47M | $ 360.70M | $ 348.29M |
| Operating Income | $ 136.95M | $ 107.28M | $ 112.63M | $ 124.48M | $ 128.20M |
| EBITDA | $ 136.95M | $ 108.32M | $ 112.63M | $ 124.48M | $ 130.44M |
| Net Income | $ 139.73M | $ 106.14M | $ 101.42M | $ 112.51M | $ 106.01M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 383.33M | $ 368.22M | $ 436.62M | $ 335.81M | $ 476.89M |
| Total Assets | $ 840.55M | $ 621.52M | $ 583.43M | $ 423.76M | $ 571.73M |
| Total Debt | $ 6.94M | $ 151.00K | $ 1.14M | $ 526.00K | $ 2.55M |
| Net Debt | $ -120.73M | $ -135.40M | $ -435.48M | $ -335.29M | $ -474.34M |
| Total Liabilities | $ 160.96M | $ 114.81M | $ 81.59M | $ 47.95M | $ 48.39M |
| Stockholders' Equity | $ 679.59M | $ 506.70M | $ 501.84M | $ 375.81M | $ 523.34M |
| Cash Flow | |||||
| Free Cash Flow | $ 195.90M | $ 126.90M | $ 119.91M | $ 167.42M | $ 150.73M |
| Operating Cash Flow | $ 198.07M | $ 127.04M | $ 120.32M | $ 167.89M | $ 151.97M |
| Investing Cash Flow | $ -177.60M | $ 90.91M | $ -114.33M | $ 136.13M | $ -119.26M |
| Financing Cash Flow | $ -28.35M | $ -148.72M | $ -17.28M | $ -302.59M | $ 12.21M |